Prudential plc’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,978
Closed -$365K 756
2024
Q4
$365K Hold
1,978
﹤0.01% 675
2024
Q3
$390K Hold
1,978
﹤0.01% 684
2024
Q2
$409K Buy
+1,978
New +$448K ﹤0.01% 641
2024
Q1
Sell
-2,365
Closed -$559K 775
2023
Q4
$559K Sell
2,365
-8
-0.3% -$1.57K 0.01% 753
2023
Q3
$465K Hold
2,373
0.01% 769
2023
Q2
$499K Sell
2,373
-15
-0.6% -$2.98K 0.01% 771
2023
Q1
$482K Buy
2,388
+8
+0.3% +$1.81K 0.01% 756
2022
Q4
$519K Buy
2,380
+1,237
+108% +$270K 0.01% 749
2022
Q3
$225K Buy
1,143
+130
+13% +$28.1K ﹤0.01% 783
2022
Q2
$217K Sell
1,013
-156
-13% -$38.1K ﹤0.01% 767
2022
Q1
$332K Buy
+1,169
New +$360K ﹤0.01% 699
2021
Q1
Sell
-8,115
Closed -$2.03M 599
2020
Q4
$2.03M Hold
8,115
0.01% 369
2020
Q3
$1.84M Sell
8,115
-847
-9% -$176K 0.01% 365
2020
Q2
$1.56M Buy
+8,962
New +$1.43M 0.01% 358

Other funds holding CRL